Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached with a protein to enhance immunogenicity and protect against invasive diseases. Asia Pacific is the fastest growing market for conjugate vaccines. The conjugate vaccines market in Asia-Pacific is expected to expand at a CAGR of 23.5%, leading...
Read MoreConjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. China is one of the prominent markets with a significant growth rate for conjugate vaccines. All Expanded Program on Immunization (EPI) vaccines (including tuberculosis, polio, measles,...
Read MoreConjugate Vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protects against invasive diseases. Japan is one of the most prominent markets of conjugate vaccines. Japan, at 84 years, has one of the highest life expectancies in the world. Currently,...
Read MoreConjugate Vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. EU5 is one of the most prominent markets for conjugate vaccines. The U.K. was the first country to introduce MenB-4C into their National Infant Immunization Program...
Read More